Treatments · Entity Annotation Prototype (beta)

2articles mentioning treatments

2treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: platinum-doublet chemotherapy ×

platinum-doublet chemotherapy

This treatment is selected. Its supporting articles are shown below.

platinum-doublet chemotherapy2

Articles mentioning platinum-doublet chemotherapy

2 articles · page 1 of 1

507 Clinical outcomes of platinum doublet chemotherapy combined with dual checkpoint inhibitors after primary resistance to dual checkpoint inhibitor therapy: results from the LONESTAR study

jitc · abstract · 2025-11-04 · 1 matching annotations

75.3%

platinum doublet chemotherapy platinum doublet therapy platinum-doublet chemotherapy ipilimumab nivolumab NSCLC MD Anderson Cancer Center non-small-cell lung cancer non-small cell lung cancer

…ell lung cancer (NSCLC) lacking actionable genomic alterations, platinum doublet chemotherapy is the standard treatment following progression on dual ICI the…

508 Biomarker analysis of coformulation of vibostolimab with pembrolizumab (vibo/pembro) with or without docetaxel for metastatic non-small-cell lung cancer (mNSCLC) after chemotherapy and immunotherapy

jitc · abstract · 2025-11-04 · 1 matching annotations

79.3%

platinum chemotherapy platinum-doublet chemotherapy anti-PD-(L)1 therapy mNSCLC docetaxel pembrolizumab vibo/pembro vibostolimab